AED 20m puts Hamdan Bin Rashid Cancer Hospital systems on the clock

Al Jalila Foundation secured AED 20 million from Easa Saleh Al Gurg Charity Foundation for engineering systems that Hamdan Bin Rashid Cancer Hospital needs before its planned 2026 opening.

The immediate audience is hospital COOs, CFOs, CIOs and oncology operators. The donation funds the power, fire alarm, evacuation and emergency battery systems that must clear testing and commissioning before Dubai Health can bring new cancer capacity online under Dubai Health Authority (DHA) oversight.

What the AED 20 million covers

The agreement was signed at Al Jalila Foundation by Dr Amer Al Zarooni, chief executive officer of Al Jalila Foundation, and Easa Al Gurg, group chief executive officer of Al Gurg Group, according to Gulf Today on 19 June 2026. Dr Raja Easa Al Gurg, chairperson of Easa Saleh Al Gurg Charity Foundation, and Dr Amer Sharif, chief executive officer of Dubai Health, attended the signing.

The funded work sits in the hospital's operating backbone. Scientechnic and Al Gurg Automation & Controls, both Al Gurg Group companies, will provide design, supply, testing and commissioning services.

• Low-voltage switchgear panels for power distribution.
• Fire alarm systems and voice evacuation systems.
• Central battery systems for emergency power.
• Factory acceptance testing, site testing and commissioning.

Landmark projects such as the Hamdan Bin Rashid Cancer Hospital represent an important investment in the future of healthcare in the UAE.
Easa Al Gurg, group chief executive officer, Al Gurg Group

Why commissioning matters

Hamdan Bin Rashid Cancer Hospital is due to open in 2026 as part of Dubai Health's academic health system. Dubai Health has previously described the project as a 116-bed specialist oncology facility with outpatient, ambulatory, diagnostic, inpatient and surgical services in one location.

For private hospitals and day-surgery groups, the number to remember is 116 beds. A public cancer hub with integrated diagnostics, inpatient capacity and research capability can affect referral flows in chemotherapy, radiation oncology, surgical oncology and survivorship care.

The regulatory map matters for any oncology group planning expansion. Providers in Dubai operate under DHA. Providers in Abu Dhabi and Al Ain report to the Department of Health Abu Dhabi (DOH), while providers in the Northern Emirates report to the Ministry of Health and Prevention (MOHAP). Capital plans should separate DHA licensing work from DOH and MOHAP requirements before site selection or vendor commitments.

Budget and vendor takeaways

For CFOs, AED 20 million is a reminder that hospital launch costs extend beyond medical equipment. Fire systems, evacuation systems, emergency power and switchgear sit outside the oncology capex items that often get board attention, including PET-CT, linear accelerators, infusion chairs and pharmacy clean rooms.

For CIOs and facilities heads, the procurement issue is integration. Oncology operations rely on scheduling, infusion capacity, pharmacy preparation, emergency response, radiation workflows and clinical research records moving through the same operating model. Hamdan Bin Rashid Cancer Hospital will need data flows that support DHA reporting, trial governance and continuity across Dubai Health sites.

The project adds a benchmark for philanthropy-backed healthcare infrastructure in Dubai. Al Jalila Foundation's 2025 impact report reported AED 435 million in donor contributions, 13 strategic healthcare initiatives and 9,737 beneficiaries across its programmes.

The next marker is commissioning progress before the 2026 opening. Operators should watch for DHA licensing milestones, Dubai Health staffing announcements and vendor handover updates, because those dates will show when Hamdan Bin Rashid Cancer Hospital shifts from funded infrastructure to active oncology capacity.